138 related articles for article (PubMed ID: 1595326)
1. Calcitonin release from medullary thyroid carcinoma by thyrotropin-releasing hormone: comparison with calcium injection.
Oishi S; Yamauchi J; Fujimoto Y; Hamasaki S; Umeda T; Sato T
Acta Endocrinol (Copenh); 1992 Apr; 126(4):325-8. PubMed ID: 1595326
[TBL] [Abstract][Full Text] [Related]
2. Is thyrotropin-releasing hormone as reliable a calcitonin stimulant as pentagastrin in medullary thyroid carcinoma?
Ahuja S
Acta Endocrinol (Copenh); 1990 May; 122(5):640-2. PubMed ID: 2112816
[TBL] [Abstract][Full Text] [Related]
3. Thyrotrophin releasing hormone induced calcitonin secretion in patients with medullary carcinoma of the thyroid.
Nakamura H; Someda H; Mori T; Imura H
Clin Endocrinol (Oxf); 1987 Jul; 27(1):69-74. PubMed ID: 3115636
[TBL] [Abstract][Full Text] [Related]
4. A comparison of calcium pentagastrin and TRH tests in screening for medullary carcinoma of the thyroid in MEN IIA.
O'Connell JE; Dominiczak AF; Isles CG; McLellan AR; Davidson G; Gray CE; Connell JM
Clin Endocrinol (Oxf); 1990 Apr; 32(4):417-21. PubMed ID: 1971777
[TBL] [Abstract][Full Text] [Related]
5. Circulating levels of calcitonin gene-related peptide in patients with medullary thyroid carcinoma.
Kim S; Morimoto S; Kawai Y; Koh E; Onishi T; Ogihara T
J Clin Chem Clin Biochem; 1989 Jul; 27(7):423-7. PubMed ID: 2794874
[TBL] [Abstract][Full Text] [Related]
6. GH response to growth hormone releasing hormone and hypoglycaemia is unaltered by high endogenous plasma calcitonin levels in patients with medullary thyroid carcinoma.
Popovic V; Micic D; Damjanovic S; Durbaba M; Petakov M; Zoric S; Djurovic M; Manojlovic D; Micic J
Clin Endocrinol (Oxf); 1991 Aug; 35(2):137-9. PubMed ID: 1934528
[TBL] [Abstract][Full Text] [Related]
7. Basal and stimulated release of calcitonin gene-related peptide (CGRP) in patients with medullary thyroid carcinoma.
Mason RT; Shulkes A; Zajac JD; Fletcher AE; Hardy KJ; Martin TJ
Clin Endocrinol (Oxf); 1986 Dec; 25(6):675-85. PubMed ID: 3498561
[TBL] [Abstract][Full Text] [Related]
8. [Discrepancy between the basal level of TSH and the thyrotropic response to TRH during thyroid hormone treatment of differentiated thyroid cancers].
Charrie A; Tourniaire J; Bernard MH; Dutey P; Andrianasolo H; Fleury-Goyon MC
Ann Endocrinol (Paris); 1989; 50(1):31-5. PubMed ID: 2499241
[TBL] [Abstract][Full Text] [Related]
9. Determination of silica-purified plasma calcitonin for the detection and management of medullary thyroid carcinoma: comparison of two provocative tests.
Gharib H; Kao PC; Heath H
Mayo Clin Proc; 1987 May; 62(5):373-8. PubMed ID: 3573825
[TBL] [Abstract][Full Text] [Related]
10. Calcitonin as a tumor marker. Use of the radioimmunoassay for calcitonin in the postoperative evaluation of patients with medullary thyroid carcinoma.
Goltzman D; Potts JT; Ridgway RC; Maloof F
N Engl J Med; 1974 May; 290(19):1035-9. PubMed ID: 4207025
[No Abstract] [Full Text] [Related]
11. Selective autonomic nervous control of thyroid hormone and calcitonin secretion during metabolic and cardiorespiratory activation by intracisternal thyrotropin-releasing hormone (TRH).
Riedel W; Burke SL
J Auton Nerv Syst; 1988 Sep; 24(1-2):157-73. PubMed ID: 3145296
[TBL] [Abstract][Full Text] [Related]
12. Reference values of serum calcitonin with calcium stimulation tests by electrochemiluminescence immunoassay before/after total thyroidectomy in Japanese patients with thyroid diseases other than medullary thyroid carcinoma.
Kihara M; Miyauchi A; Kudo T; Hirokawa M; Miya A
Endocr J; 2016 Jul; 63(7):627-32. PubMed ID: 27097651
[TBL] [Abstract][Full Text] [Related]
13. [Radioimmunoassay of the calcitonin gene-related peptide and its measurement in the plasma of patients with medullary thyroid carcinoma and in the cerebrospinal fluid of normal subjects].
Kim S; Morimoto S; Fukuo K; Hironaka T; Koh E; Shiraishi T; Onishi T; Kumahara Y; Kawai Y; Shiotani Y
Nihon Naibunpi Gakkai Zasshi; 1987 Jul; 63(7):884-93. PubMed ID: 3500074
[TBL] [Abstract][Full Text] [Related]
14. Screening for medullary carcinoma of the thyroid in families with Sipple's syndrome: evaluation of new stimulation tests.
Telenius-Berg M; Almqvist S; Berg B; Hedner P; Ingemansson S; Tibblin S; Wasthed B
Eur J Clin Invest; 1977 Feb; 7(1):7-16. PubMed ID: 402280
[TBL] [Abstract][Full Text] [Related]
15. Peroperative studies of S-calcitonin in thyroid and peripheral venous samples from patients with normal C-cells, C-cell hyperplasia, and medullary carcinoma on the thyroid.
Ericsson M; Berg M; Ingemansson S
Res Exp Med (Berl); 1983; 182(2):139-47. PubMed ID: 6867477
[TBL] [Abstract][Full Text] [Related]
16. Calcium infusion and pentagastrin injection in diagnosis of medullary thyroid carcinoma.
Verdy M; Cholette JP; Cantin J; Lacroix A; Sturtridge WC
Can Med Assoc J; 1978 Jul; 119(1):29-35. PubMed ID: 679097
[TBL] [Abstract][Full Text] [Related]
17. A cut-off value of basal serum calcitonin for detecting macroscopic medullary thyroid carcinoma.
Kwon H; Kim WG; Choi YM; Jang EK; Jeon MJ; Song DE; Baek JH; Ryu JS; Hong SJ; Kim TY; Kim WB; Shong YK
Clin Endocrinol (Oxf); 2015 Apr; 82(4):598-603. PubMed ID: 25041034
[TBL] [Abstract][Full Text] [Related]
18. The effects of L-dopa on in vitro and in vivo calcitonin release from medullary thyroid carcinoma.
Baylin SB; Hsu TH; Stevens SA; Kallman CH; Trump DL; Beaven MA
J Clin Endocrinol Metab; 1979 Mar; 48(3):408-14. PubMed ID: 218991
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum calcitonin levels in patients with thyroid disorders.
Oishi S; Shimada T; Tajiri J; Inoue J; Sato T
Acta Endocrinol (Copenh); 1984 Dec; 107(4):476-81. PubMed ID: 6516695
[TBL] [Abstract][Full Text] [Related]
20. Determination of plasma calcitonin gene-related peptide concentrations by a new immunochemiluminometric assay in normal persons and patients with medullary thyroid carcinoma and other neuroendocrine tumors.
Carter WB; Taylor RL; Kao PC; Heath H
J Clin Endocrinol Metab; 1991 Feb; 72(2):327-35. PubMed ID: 1991803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
